In contrast to the earlier study, which found that the activation of EGFR signaling mediates HCMV entry into CD34+ HPCs as well as the establishment of latency [168], Buehler et al., assert that HCMV actually downregulates EGFR and decreases EGFR activation early in infection. The gene discussed is CD34; the disease is infection.